4 Analysts Have This to Say About Core Laboratories
Portfolio Pulse from Benzinga Insights
Four analysts have given their ratings on Core Laboratories (NYSE:CLB) over the last quarter, with two being indifferent, one somewhat bearish, and one bearish. The average price target is $21.62, which is lower than the current price of $24.35, implying a downside. The average price target has increased by 1.36% over the past month.
June 30, 2023 | 12:06 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Analysts' average price target for Core Laboratories is lower than its current price, indicating a potential downside.
The average price target given by analysts is a key indicator of where they believe the stock will be in the near future. In this case, the average price target for Core Laboratories is lower than its current price, which suggests that the analysts believe the stock price may decrease in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100